Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Cosmetics Bill Imminent With Small – And Big – Business Support

Executive Summary

A second bill to enhance FDA's oversight of the cosmetics industry is expected to be introduced in the next few weeks, according to Independent Cosmetic Manufacturers and Distributors President and CEO Pam Busiek. The bill will launch in the House – likely with bipartisan support – and be modeled after 2012's Cosmetic Safety Amendments Act, she said.

Advertisement

Related Content

In Brief: Alternate Cosmetics Bill Pushed Back; ECHA Finds Unapproved Animal Tests; More
Editorial: Will Next Anti-Aging Market Disruptor Be Anti-Anti-Aging?
Feinstein Bill Lacks ‘Crucial’ National Uniformity Assurance – ICMAD
Sen. Feinstein’s Cosmetics Safety Bill Launches With GOP Cosponsor
Council-Approved Cosmetics Safety Bill Launches
Advertisement
UsernamePublicRestriction

Register

RS019522

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel